翻訳と辞書 |
Empagliflozin : ウィキペディア英語版 | Empagliflozin
Empagliflozin (trade name Jardiance) is a drug of the gliflozin class, approved for the treatment of type 2 diabetes in adults in 2014. It was developed by Boehringer Ingelheim and Eli Lilly and Company. Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and causes sugar in the blood to be excreted by the kidneys and eliminated in ]. == Side effects ==
When taken in dosages of 10 or 25 mg once a day, the incidence of adverse events was similar to placebo. However, there was a higher frequency of genital infections.〔Miriam E. Tucker for Medscape Medical News. May 07, 2013 (First Details of Empagliflozin Trials Follow US and EU Filings )〕〔NICE. (Type 2 diabetes: empagliflozin )〕 There are concerns it may increase the risk of diabetic ketoacidosis.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Empagliflozin」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|